Company: MDCXW
Filing Date: 2025-09-11
Form Type: DRS
Source: 0001062993-25-015568
Chunk: 232

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-11
Form: DRS
Chunk 232
---
 August 31, 2025. The number of common shares in the column entitled "Maximum Number of Common Shares Being Offered" represents all of the common shares being offered for resale by the Selling Shareholder under this prospectus. The Selling Shareholder may sell some, all, or none of the shares being offered for resale in this offering. We do not know how long the Selling Shareholder will hold the shares before selling them, and we are not aware of any existing arrangements between the Selling Shareholder and any other shareholder, broker, dealer, underwriter, or agent relating to the sale or distribution of the common shares being offered for resale by this prospectus.

Beneficial ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act and includes common shares with respect to which the Selling Shareholder has sole or shared voting and investment power. The percentage of common shares beneficially owned by the Selling Shareholder prior to the offering shown in the table below is based on an aggregate of 20,218,104 common shares outstanding on August 31, 2025. Because the purchase price to be paid by the Selling Shareholder for common shares, if any, that we may elect to sell to the Selling Shareholder in one or more Advances from time to time under the SEPA will be determined on the applicable dates for such Advances, the actual number of common shares that we may sell to the Selling Shareholder under the SEPA may be fewer than the number of shares being offered for resale under this prospectus. The fourth column in the table below assumes the resale by the Selling Shareholder of all of the common shares being offered for resale pursuant to this prospectus.

We have determined beneficial ownership in accordance with the rules of the SEC.

|                   |     | Number of Common Shares 
      Beneficially Owned |     |         |     |   Maximum Number of 
 Common Shares Being 
             Offered |           | Common Shares Beneficially Owned After the 
 Offered Common Shares Are Sold             |         |   |
| Name of Selling   
 Securityholder    |     |               Number(1) |     | Percent |     |                     | Number(2) |                                            | Percent |   |
| YA II PN, Ltd.(3) |     |                 100,000 |     | *       |     |           7,500,000 |           | -                                          |         | * |

*Less than one percent.

(1)Represents common shares